CVS Health Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Strong Buy" and an average price target of $116.08. The average 1-year stock price forecast is 24.72% higher than the current stock price, while the lowest is $103 (+10.67%) and the highest is $148 (+59.02%).

Price Target: $116.08 (+24.72%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$103	$116.08	$116	$148
Change	+10.67%	+24.72%	+24.64%	+59.02%

Analyst Ratings

The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	18	18	18	18	18	18
Buy	7	7	6	6	6	6
Hold	4	3	4	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	29	28	28	28	28	27

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Steven Silver Argus Research	Argus Research	Buy Maintains $104 → $114	Buy	Maintains	$104 → $114	+22.49%	Aug 19, 2026
Lance Wilkes Bernstein	Bernstein	Buy Reiterates $106	Buy	Reiterates	$106	+13.89%	Aug 12, 2026
Lisa Gill J.P. Morgan	J.P. Morgan	Buy Maintains $111 → $118	Buy	Maintains	$111 → $118	+26.79%	Aug 12, 2026
Stephen Baxter Wells Fargo	Wells Fargo	Buy Reiterates $123	Buy	Reiterates	$123	+32.16%	Aug 11, 2026
Erin Wright Morgan Stanley	Morgan Stanley	Buy Reiterates $111	Buy	Reiterates	$111	+19.27%	Aug 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

417.73B

from 399.83B

4.47%

from 399.83B

Revenue Next Year

429.63B

from 417.73B

2.85%

from 417.73B

EPS This Year

7.95

from 6.75

17.76%

from 6.75

EPS Next Year

8.51

from 7.95

7.02%

from 7.95

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	290.91B	321.63B	356.62B	370.66B	399.83B	417.73B
Revenue Growth	8.59%	10.56%	10.88%	3.94%	7.87%	4.47%
Gross Profit	50.92B	53.66B	53.28B	49.25B	53.13B	59.63B
Gross Margin	17.50%	16.69%	14.94%	13.29%	13.29%	14.28%
Operating Income	14.16B	15.74B	14.07B	8.02B	10.02B	16.76B
Net Income	8.00B	4.31B	8.34B	4.61B	1.77B	8.80B
EPS	-	-	-	-	6.75	7.95
EPS Growth	-	-	-	-	24.54%	17.76%
Forward PE	12.88	10.67	9.39	7.77	11.54	11.71
Dividend / Share	2.00	2.20	2.42	2.66	2.66	2.66
Dividend Growth	-	10.00%	10.00%	9.92%	-	-0.01%
Free Cash Flow	14.78B	11.94B	11.08B	6.91B	5.93B	7.89B
No. Analysts	-	-	-	-	-	20

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	425.8B
Avg	417.7B
Low	414.2B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	6.5%
Avg	4.5%
Low	3.6%

EPS Forecast

Chart

EPS	2026	2027	2028
High	8.15
Avg	7.95
Low	7.37

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	20.8%
Avg	17.8%
Low	9.2%